is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), the virus that causes coronavirus disease 2019 (COVID‑19).
EMA’s human medicines committee (CHMP) has started a rolling review of the vaccine against Covid-19 of the biotechnological pharmaceutical company HIPRA.
The HIPRA’s Covid-19...
Moderna, Inc., on Wednesday announced the finalization of a strategic partnership with the Australian Federal Government to establish a state-of-the-art, domestic mRNA vaccine manufacturing...
Moderna, Inc., today announced positive interim data from the Phase 2/3 KidCOVE study of the Moderna COVID-19 vaccine (mRNA-1273) in children 6 months to...
Strides Pharma Science Ltd., a global pharmaceutical company, today announced a sub-license agreement with MPP to commercialize a generic version of Pfizer’s COVID-19 oral...
South Korea's state health center has signed a pre-purchase contract for 10 million doses of a COVID-19 vaccine candidate codenamed GBP510 being developed by...
Alnylam Pharmaceuticals, Inc. announced that it has separately filed suit in United States District Court for the District of Delaware against Pfizer, Inc. and...